AbbVie Inc. (ABBV) vs The Procter & Gamble Company (PG)
See how AbbVie Inc. and The Procter & Gamble Company differ across market data and performance, so you can decide which asset best fits your strategy.
$284.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page$156.28
NYSE
Founded in 1837, Procter & Gamble Company (PG) has grown into one of the world’s largest consumer goods manufacturers, generating nearly $85 billion in annual sales. Its portfolio includes many leading brands, with more than 20 producing over $1 billion in global annual revenue each, including Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. International markets account for slightly more than half of the company’s consolidated sales.
View Full PageKey Metrics Comparison
AbbVie Inc.ABBV
Market Cap$502.604B
Price$284.42
24h Change+3.67%
24h Volume$2.75M
Employees57,000
Shares Outstanding1,768,169,012
The Procter & Gamble CompanyPG
Market Cap$363.262B
Price$156.28
24h Change+2.12%
24h Volume$5.27M
Employees109,000
Shares Outstanding2,328,598,978
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ABBV
58.0%PG
42.0%Volume Share
Share of combined 24h volume
ABBV
34.3%PG
65.7%24h Performance
Price change over last 24 hours
ABBV
3.67%PG
2.12%Price Comparison
AbbVie Inc.
The Procter & Gamble Company